EquiReason research coverage
111, Inc. YI
Healthcare · Pharmaceutical Retailers
Segments it reports
The business segments 111, Inc. reports in its own SEC filings.
Product lines it reports
The product and service lines 111, Inc. breaks its revenue into.
What we read
The sources behind this company, and how many records of each we hold.
- Financial statements27
- Quarterly metric series12
- Business segments2
- SEC filings12
- Insider transactions (Form 4)6
- Institutional positions (13F)7
- Earnings quality checks5
- Estimate revisions11
- GAAP vs non-GAAP reconciliation1
- Seasonal pattern6
- Multi-period trajectory7
- Fiscal calendar1
- Index membership4
What we look for
Every company is run through the same checks. Both answers are reported — a signal we looked for and did not find is as much a fact as one we did.
- Revenue series4
- Operating cash flow series1
- Guidance changesnot found
- Margin seriesnot found
- Cash flow seriesnot found
- Earnings seriesnot found
- Per-share seriesnot found
This page says how much of 111, Inc. we have read. What any of it means — the direction, the dates, the evidence and what would overturn it — is inside the product.
Open YI in EquiReasonThis page publishes coverage counts and reported breakdown names, but no financial figures, price data, rankings or investment conclusions. Sources are SEC filings, earnings calls and public institutional disclosures. How the research is made · All companies